Efficacy of clofazimine and nitazoxanide combination in treating intestinal cryptosporidiosis and enhancing intestinal cellular regeneration in immunocompromised mice.

Autor:	Esmat M; Department of Medical Parasitology, Faculty of Medicine, Misr University for Science and Technology, 6th October city, Egypt., Abdel-Aal AA; Department of Medical Parasitology, Faculty of Medicine, Cairo University, Egypt.; Department of Postgraduate Studies & Scientific Research, Armed Forces College of Medicine (AFCM), Cairo, Egypt., Shalaby MA; Medical Parasitology Department, Theodor Bilharz Research Institute (TBRI), Giza, Egypt., Badawi M; Department of Pathology, National Research center, Giza, Egypt., Elaskary H; Depatment of Medical Parasitology, Faculty of Medicine, Beni-Suef University, Beni Suef, Egypt., Yousif AB; Department of Medical Parasitology, Faculty of Medicine, Fayoum University, Faiyum, Egypt., Fahmy MA; Medical Parasitology Department, Theodor Bilharz Research Institute (TBRI), Giza, Egypt.
Jazyk:	angličtina
Zdroj:	Food and waterborne parasitology [Food Waterborne Parasitol] 2022 May 04; Vol. 27, pp. e00161. Date of Electronic Publication: 2022 May 04 (Print Publication: 2022).
DOI:	10.1016/j.fawpar.2022.e00161
Abstrakt:	Cryptosporidium is a widely distributed food and water-borne enteric protozoan that affects a wide range of vertebrates, resulting in life-threatening consequences, particularly in immunocompromised hosts. The lack of effective anti-cryptosporidial drugs may be related to the parasite's unique intestinal location, plus the lack of studies on the process by which the protozoan is able to impair intestinal cellular function. The present work aimed to assess the effect of clofazimine (CFZ), an FDA-approved drug for the treatment of leprosy, as an anti-cryptosporidial drug, using transmission electron microscopy (TEM) and an immunocompromised mouse model. The affected intestinal mucosa with parasitic stages in the infected non-treated group showed signs of severe cellular degeneration, including the loss of tight junctions, deformed and damaged microvilli and irregularly distributed nuclei with a severely vacuolated cytoplasm. Comparatively, nitazoxanide (NTZ) monotherapy showed the lowest efficacy as the drug was associated with the lowest rate of oocyst shedding. In addition, NTZ treatment failed to achieve the return of complete cellular function; abnormalities were evident in the microvilli, cytoplasmic organelles and nuclear features. Clofazimine demonstrated an improvement of the mucosal cellular components, including mitochondria and significantly reduced oocyst shedding. Combined treatment with low-dose CFZ and half-dose NTZ resulted in a significant improvement in the enterocyte cellular structures with an absence of intracellular parasitic stages. These results indicate that CFZ, a safe and readily prescribed drug, effectively reduces cryptosporidiosis when used in combination with only half the dose of NTZ. Used in combination, these drugs were shown to be efficient in regaining intestinal cellular activity following Cryptosporidium- induced functional damage in an immunocompromised mouse model. Competing Interests: The authors whose names are listed immediately below certify that they have NO affiliations with or involvement in any organization or entity with any financial interest (such as honoraria; educational grants; participation in speakers' bureaus; membership, employment, consultancies, stock ownership, or other equity interest; and expert testimony or patent-licensing arrangements), or non-financial interest (such as personal or professional relationships, affiliations, knowledge or beliefs) in the subject matter or materials discussed in this manuscript. (© 2022 The Authors.)
Databáze:	MEDLINE
Externí odkaz:	Zobrazit plný text záznamu